Apixaban Compared to Rivaroxaban for A-Fib and Valvular Heart Disease

WEDNESDAY, Oct. 19, 2022 -- For patients with atrial fibrillation (AF) and valvular heart disease (VHD), apixaban is associated with a reduced risk for ischemic stroke or systemic embolism and a reduced risk for bleeding compared with rivaroxaban,...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news